Myasthenia Gravis Attack after Oral Risperidone Treatment: A Case Report

The Eurasian Journal of Medicine
Hakan OgutluOnur Burak Dursun

Abstract

Myasthenia gravis (MG) is an autoimmune disease, which can be triggered by anticholinergic agents. The 6-year-old female patient was admitted to the outpatient clinic. She was had been previously diagnosed with comorbid attention deficit hyperactivity disorder and conduct disorder and was receiving short-acting methylphenidate and risperidone, as recommended by a child psychiatrist. However, after using the drugs, she stated that she was overly tired during the day and that her eyelids drooped. Hence, the current treatment was stopped. She was hospitalized with a prediagnosis of ocular type MG and pyridostigmine (90 mg/day) treatment was started. The patient recovered and subsequently the treatment was stopped. Since psychiatric symptoms of the patient resurfaced, long-acting methylphenidate treatment was initiated. During this treatment, the symptoms of MG did not return. The Naranjo's scale of adverse drug reaction probability was completed. Consequently, there may be an association between risperidone and MG.

Citations

Sep 8, 2020·Expert Opinion on Drug Safety·Felice IasevoliAndrea de Bartolomeis
Jul 9, 2021·Neurological Research·Dejan Z AleksićDragana Lavrnić
Aug 3, 2021·Progress in Neuro-psychopharmacology & Biological Psychiatry·Mathieu Di MiceliBenjamin Gronier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Related Papers

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
J Lexchin
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
S M Brostë
Progress in Neuro-psychopharmacology & Biological Psychiatry
Sabri Hergüner, Arzu Samur Hergüner
© 2022 Meta ULC. All rights reserved